Skip to main content

Day: July 2, 2024

Alvotech Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®

Positive topline results demonstrate clinical similarity between AVT03 and the reference biologic, Prolia® (denosumab) Two additional studies comparing the pharmacokinetics, safety, and tolerability of AVT03 to Prolia and Xgeva, respectively, have also met their primary endpoint Alvotech expects to file marketing applications for AVT03 later this year for major global marketsAlvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today positive topline results from a confirmatory patient study for AVT03, a proposed biosimilar to Prolia® (denosumab) and Xgeva® (denosumab). The study met its primary endpoints. The objective of the study is to demonstrate clinical similarity of AVT03 to Prolia in terms of efficacy, safety, immunogenicity,...

Continue reading

SAGA Metals to Acquire Amirault Lithium Property in Québec

Acquisition turns Saga Metals into the largest contiguous landowner in Eastern James Bay focused on Hard Rock Lithium Exploration VANCOUVER, British Columbia, July 02, 2024 (GLOBE NEWSWIRE) — Saga Metals Corp. (the “Company” or “Saga”), a North American exploration company focused on critical mineral discovery in Canada, is pleased to announce that it has entered into an asset purchase agreement (the “APA”) with two arm’s length private vendors (the “Vendors”), pursuant to which the Company will acquire a 100% interest in 606 mining claims covering an area of 31,347.76 hectares in the Eeyou Istchee James Bay region of Québec (the “Amirault Property”). The Amirault Lithium Property is contiguous to Saga’s Legacy Lithium project expanding the total contiguous land holdings to 1,274 claims spanning 65,849.20 hectares (658 square kilometers)....

Continue reading

Plastic Market to Surpass USD 867.43 Billion by 2031, Witnessing 4.2% CAGR Growth | SkyQuest Technology

Westford, July 02, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Plastic Market will attain a value of USD 867.43 Billion by 2031, with a CAGR of 4.2% during the forecast period (2024-2031). Plastic is utilized in nearly every industry, such as building and construction, transportation, industrial machinery, electrical & electronics, consumer items, textiles, packaging, and more. Globally, above one million plastic bags are used per minute. Several types of plastics are used every day, but polyethylene is the most widely used plastic. It is commonly used in 3 forms: low-density, high-density, and linear low-density. Among these, the high-density (HDPE) is the toughest one and holds major applications in food packaging. Download a detailed overview: https://www.skyquestt.com/sample-request/plastic-market Browse...

Continue reading

Fortinet to Announce Second Quarter 2024 Financial Results

SUNNYVALE, Calif., July 02, 2024 (GLOBE NEWSWIRE) — News Summary Fortinet® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, announced that it will hold a conference call to discuss its second quarter 2024 financial results on Tuesday, August 6, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time). Fortinet’s financial results conference call will be broadcast live in listen-only mode on the company’s investor relations website at http://investor.fortinet.com. While not required, it is recommended that you join at least 10 minutes prior to the event start. The CEO and CFO’s prepared remarks, supplemental slides and a call replay will be accessible from the Quarterly Earnings page on the Investor Relations page of Fortinet’s website at https://investor.fortinet.com/quarterly-earnings. About...

Continue reading

From Call to Care: ESO Acquires Logis Solutions, Reinventing Emergency Response

ESO positioned to offer the first interoperable CAD solution connecting dispatch through patient outcomes AUSTIN, Texas, July 02, 2024 (GLOBE NEWSWIRE) — ESO, a leading data and software company serving emergency medical services (EMS), fire departments, hospitals, state and federal agencies, has acquired Logis Solutions, a global leader offering complementary computer-aided dispatch (CAD), logistics and billing software to EMS, fire departments, emergency communication centers and hospitals. ESO and Logis are uniting to integrate data and workflows from call taking, dispatch and billing across the emergency response continuum. The Logis logistics software builds on ESO’s foundation serving EMS, fire departments, and hospitals and extends ESO’s data-driven insights to dispatch and emergency communication centers, while enhancing...

Continue reading

Cross Keys Capital Advises New Jersey Cancer Care, PA, in Its Partnership with Regional Cancer Care Associates

Fort Lauderdale, July 02, 2024 (GLOBE NEWSWIRE) — Cross Keys Capital, LLC, a leading independent investment banking firm providing M&A advisory services to physician group practices and healthcare services companies, is pleased to announce it acted as the exclusive financial advisor to New Jersey Cancer Care, PA, (NJCC) in its partnership with Regional Cancer Care Associates (RCCA), a strategic partner of The US Oncology Network. NJCC consists of eight medical oncologists and eleven total providers operating across three offices in the North Jersey market. NJCC is one of the largest independent medical oncology groups in New Jersey and is led by Dr. James Orsini, Sr. NJCC has served the North Jersey marketplace since its founding in 1998 and continues to be a leader in community-based cancer care within the region. The partnership...

Continue reading

Digital Health Market to Reach USD 881 Billion by 2031, Growing at 18.6% CAGR | SkyQuest Technology

Westford, July 02, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Digital Health Market will attain a value of USD 881 Billion by 2031, with a CAGR of 18.6% during the forecast period (2024-2031). Digital health adopts digital platforms and tools to enhance patient quality by offering personalized care to patients, using neural networks to treat diseases, and expanding healthcare access via mobile applications. With the growing awareness of digital health, consumers across the globe are seeking well-being solutions and digital health fitness to enhance their health. Moreover, online consultation of physicians has witnessed major growth since people prefer more timely and convenient medical counseling.  Download a detailed overview: https://www.skyquestt.com/sample-request/digital-health-market Browse in-depth TOC on...

Continue reading

Radius Recycling Reports Third Quarter Fiscal 2024 Financial Results

Ferrous, Nonferrous and Finished Steel Sales Volumes Up Sequentially Radius Board Declares Quarterly Dividend PORTLAND, Ore., July 02, 2024 (GLOBE NEWSWIRE) — Radius Recycling, Inc. (NASDAQ: RDUS) today reported results for the third quarter of fiscal 2024 ended May 31, 2024. The Company’s reported and adjusted results differed significantly this quarter. Due primarily to a non-cash goodwill impairment charge reflecting the challenging market conditions for recycled metals experienced during the last year, the Company reported a loss per share from continuing operations of $(6.97) and a net loss of $(199) million in the third quarter. These results included a goodwill impairment charge of $216 million or $(6.21) per share net of taxes and compared to a reported loss per share of $(1.19) and net loss of $(34) million in the second...

Continue reading

Positive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presented at ISPNO 2024

July 2, 2024 Biodexa Pharmaceuticals PLC Positive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presented at ISPNO 2024 After Only Two Infusions and Two Patients at Optimal Dose, Median Overall Survival Across all Patients was 16.5 Months (vs 10.0 Months in Historical Reference Cohort) (DATELINE) JULY 2 — Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, announces data from a Phase 1 study of MTX110 in Diffuse Midline Glioma (“DMG”) f/k/a Diffuse Intrinsic Pontine Glioma, or DIPG, an orphan pediatric brain cancer were presented over the weekend at the 21st International Symposium on Pediatric Neuro-Oncology...

Continue reading

Puma Exploration Provides Update on Transactions with Raptor Resources

RIMOUSKI, Quebec, July 02, 2024 (GLOBE NEWSWIRE) — Puma Exploration Inc. (TSXV: PUMA, OTCQB: PUMXF) (the “Company” or “Puma”) is pleased to provide an update on its sale agreements with Raptor Resources Ltd. (“Raptor”) and Canadian Copper Inc. (“Canadian Copper”) respecting the sale and transfer to Raptor of the Chester and Turgeon Projects (see Figure 1) located in New Brunswick, Canada for a total possible consideration of AUD$2,000,000 in cash and shares as outlined in its March 4, 2024, News Release. Raptor has recently informed Puma and Canadian Copper that the prospectus relating to its initial public offering of at least AUD$10,000,000 will be lodged with the Australian Securities Exchange (“ASX”) on or before July 15, 2024. Pursuant to the sale agreement on Chester, Raptor was required to prepare and lodge a prospectus...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.